These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 21802908)
1. Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation. Hansali F; Poisson G; Wu M; Bendedouch D; Marie E Colloids Surf B Biointerfaces; 2011 Nov; 88(1):332-8. PubMed ID: 21802908 [TBL] [Abstract][Full Text] [Related]
2. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): dextran-based surfactants. Wu M; Dellacherie E; Durand A; Marie E Colloids Surf B Biointerfaces; 2009 Feb; 69(1):141-6. PubMed ID: 19147334 [TBL] [Abstract][Full Text] [Related]
3. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. 2. PEG-based surfactants. Wu M; Dellacherie E; Durand A; Marie E Colloids Surf B Biointerfaces; 2009 Feb; 69(1):147-51. PubMed ID: 19027270 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization. Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion. Huang CY; Chen CM; Lee YD Int J Pharm; 2007 Jun; 338(1-2):267-75. PubMed ID: 17368981 [TBL] [Abstract][Full Text] [Related]
6. Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography. Bootz A; Russ T; Gores F; Karas M; Kreuter J Eur J Pharm Biopharm; 2005 Aug; 60(3):391-9. PubMed ID: 15996580 [TBL] [Abstract][Full Text] [Related]
7. Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles. Reddy LH; Murthy RR Acta Pharm; 2004 Jun; 54(2):103-18. PubMed ID: 15274754 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. He M; Zhao Z; Yin L; Tang C; Yin C Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302 [TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres. Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657 [TBL] [Abstract][Full Text] [Related]
10. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles. Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943 [TBL] [Abstract][Full Text] [Related]
11. Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain. Lin Y; Pan Y; Shi Y; Huang X; Jia N; Jiang JY Nanotechnology; 2012 Apr; 23(16):165101. PubMed ID: 22460562 [TBL] [Abstract][Full Text] [Related]
12. Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion. Weiss CK; Lorenz MR; Landfester K; Mailänder V Macromol Biosci; 2007 Jul; 7(7):883-96. PubMed ID: 17595680 [TBL] [Abstract][Full Text] [Related]
13. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles. Jin X; Huang A; Ping Q; Cao F; Su Z Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067 [TBL] [Abstract][Full Text] [Related]
14. On inverse miniemulsion polymerization of conventional water-soluble monomers. Capek I Adv Colloid Interface Sci; 2010 Apr; 156(1-2):35-61. PubMed ID: 20199767 [TBL] [Abstract][Full Text] [Related]
15. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. Bootz A; Vogel V; Schubert D; Kreuter J Eur J Pharm Biopharm; 2004 Mar; 57(2):369-75. PubMed ID: 15018998 [TBL] [Abstract][Full Text] [Related]
16. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Joshi SA; Chavhan SS; Sawant KK Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869 [TBL] [Abstract][Full Text] [Related]
18. Advanced characterization and refinement of poly N-butyl cyanoacrylate microbubbles for ultrasound imaging. Fokong S; Siepmann M; Liu Z; Schmitz G; Kiessling F; Gätjens J Ultrasound Med Biol; 2011 Oct; 37(10):1622-34. PubMed ID: 21924206 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175 [TBL] [Abstract][Full Text] [Related]
20. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]